Literature DB >> 2441999

Discrimination of hepatocyte-stimulating activity from human recombinant tumor necrosis factor alpha.

T Andus, P C Heinrich, J Bauer, T A Tran-Thi, K Decker, D Männel, H Northoff.   

Abstract

The involvement of tumor necrosis factor alpha (TNF alpha) in the regulation of acute-phase protein synthesis is currently under discussion. In this study the effect of human recombinant TNF alpha on the regulation of the 4 acute-phase proteins alpha 2-macroglobulin, albumin, alpha 1-proteinase inhibitor and alpha 1-acute-phase globulin was investigated in rat hepatocyte primary cultures. No changes in synthesis of any of the 4 proteins were observed. However, an acute-phase response similar to that in vivo could be generated by conditioned media from human monocytes containing natural TNF alpha. This response remained unchanged after neutralizing TNF alpha activity by the addition of a specific antibody to TNF alpha. It is concluded that the hepatocyte-stimulating activity synthesized by human monocytes is different from TNF alpha.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441999     DOI: 10.1002/eji.1830170817

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Complement biosynthesis by mononuclear phagocytes.

Authors:  A R McPhaden; K Whaley
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 2.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

3.  Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia.

Authors:  D A Brenner; M Buck; S P Feitelberg; M Chojkier
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Effect of interferon-gamma on complement gene expression in different cell types.

Authors:  D F Lappin; D Guc; A Hill; T McShane; K Whaley
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

5.  Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells.

Authors:  R U Jänicke; F H Lee; A G Porter
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

6.  Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas.

Authors:  B Wiedenmann; P Reichardt; U Räth; L Theilmann; B Schüle; A D Ho; E Schlick; J Kempeni; W Hunstein; B Kommerell
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

7.  Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6.

Authors:  U Ganter; R Arcone; C Toniatti; G Morrone; G Ciliberto
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

8.  Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.

Authors:  D N Männel; A Kist; A D Ho; U Räth; P Reichardt; B Wiedenmann; E Schlick; H Kirchner
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

9.  Enhancement of experimental metastasis by tumor necrosis factor.

Authors:  P Orosz; B Echtenacher; W Falk; J Rüschoff; D Weber; D N Männel
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.